It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 | Mumbai, Maharashtra, India | ActiveSaswat Pharmaceutical (India) Private Limited, a active private limited company, was established on 23 January 2013 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24297MH2013PTC239939. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Its leadership includes Premananda Lenka (Director), Dipti Lenka (Director). Past directors included Dusmanta Kumar Rana, Nihar Ranjan Lenka. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Times Square 7Th&8Th Flr ,Cts 349 & 349-1 W-E Highway,Nr Sai Service, Andher(East), Mumbai, Maharashtra, 400069.
U24297MH2013PTC239939
239939
23 January 2013
₹1.50 M
₹1.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Saswat Pharmaceutical (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Premananda Lenka | Director | 03 Feb 2017 | Current |
| Dipti Lenka | Director | 02 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Jan 2017 | Past |
| Pramod Abcsdd | Director | 12 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saswat Pharmaceutical (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Saswat Pharmaceutical (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Saswat Pharmaceutical (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Saswat Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saswat Pharmaceutical (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Saswat Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Saswat Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Premananda Lenka was appointed as a Director was appointed as a Director on 03 Feb 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The activity Dipti Lenka was appointed as a Director was appointed as a Director on 02 Dec 2016 & has been associated with this company since 8 years 11 months . was completed.
Progress on Saswat Pharmaceutical (India) Private Limited was registered on 23 Jan 2013 with Roc Mumbai & aged 12 years 10 months as per MCA records. was documented.
The CIN of Saswat Pharmaceutical (India) Private Limited is U24297MH2013PTC239939.
Saswat Pharmaceutical (India) Private Limited is headquartered at Times Square 7Th&8Th Flr ,Cts 349 & 349-1 W-E Highway,Nr Sai Service, Andher(East), Mumbai, Maharashtra, 400069.
Saswat Pharmaceutical (India) Private Limited was incorporated on 23 January 2013.
The current directors of Saswat Pharmaceutical (India) Private Limited are
The primary industry of Saswat Pharmaceutical (India) Private Limited is Manufacturing.
Saswat Pharmaceutical (India) Private Limited is unlisted.
The authorized capital of Saswat Pharmaceutical (India) Private Limited is ₹1.50 M, and the paid-up capital is ₹1.20 M.
The compliance status of Saswat Pharmaceutical (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX